Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:ENTA’

Were Hedge Funds Right About Enanta Pharmaceuticals Inc (ENTA)?

Hedge funds don’t get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don’......(read more)
FARALLON CAPITAL

Is Enanta Pharmaceuticals Inc (ENTA) A Good Stock To Buy?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows......(read more)
Paul Marshall Marshall Wace

Enanta Pharmaceuticals Inc (ENTA): Hedge Funds In Wait-and-See Mode

We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and......(read more)

Here’s What Hedge Funds Think About Enanta Pharmaceuticals Inc (ENTA)

Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that......(read more)

Here is What Hedge Funds Think About Enanta Pharmaceuticals Inc (ENTA)

Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Hedge Funds Are Crazy About Enanta Pharmaceuticals Inc (ENTA)

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of......(read more)

These Are Apex Capital Management’s Top Biotech Stock Picks

Founded in 1987, Apex Capital Management invests mainly in companies that have market caps of up to $10 billion and is currently overseeing $6.5 billion......(read more)
Akorn, Inc. (NASDAQ:AKRX)

Akorn, Inc. (AKRX), United Therapeutics Corporation (UTHR) Among Consonance Capital’s Winning Bets in Healthcare

The $5.50 billion pharmaceutical company Akorn, Inc. (NASDAQ:AKRX) was one of the top gainers on Wednesday, closing the session with an almost 10% gain......(read more)

Apple Inc. (AAPL), BioDelivery Sciences International Inc. (BDSI) Among Thomas Bailard’s Top Q2 Top Picks

Thomas Bailard is the co-founder and current manager of Bailard Inc. Located in California, Bailard uses quantitative and fundamental analyses to choose......(read more)
United Therapeutics Corporation (NASDAQ:UTHR)

Consonance Capital Management is Fond of Healthcare Stocks

Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD. The firm usually invests in the lower......(read more)

Ra Capital Management Reveals New Stake in Enanta Pharmaceuticals Inc (ENTA)

Peter Kolchinsky‘s Ra Capital Management disclosed a new position in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). According to a 13G filing, the......(read more)

Netflix, Inc. (NFLX) Just One of Three Stocks With Upgrades That Moved Against the Market

Editor’s Note: Related tickers: Netflix, Inc. (NASDAQ:NFLX), MarketAxess Holdings Inc. (NASDAQ:MKTX), Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)......(read more)